Positron emission tomography 18F-fluorodeoxyglucose uptake and prognosis in patients with surgically treated, stage I non-small cell lung cancer: a systematic review.
about
Prognostic Value of 18F-FDG PET/CT in Surgical Non-Small Cell Lung Cancer: A Meta-AnalysisThe use and misuse of positron emission tomography in lung cancer evaluationMaximum standardized uptake value on FDG-PET predicts survival in stage I non-small cell lung cancer following carbon ion radiotherapy.Utilisation of search filters in systematic reviews of prognosis questions.Principal component analysis based feature extraction approach to identify circulating microRNA biomarkers.Sunlight may increase the FDG uptake value in primary tumors of patients with non-small cell lung cancer.ERK and AKT phosphorylation status in lung cancer and emphysema using nanocapillary isoelectric focusing.Novel positron emission tomography tracer distinguishes normal from cancerous cells.Prognositc significance of SUVmax on pretreatment 18 F-FDG PET/CT in early-stage non-small cell lung cancer treated with stereotactic body radiotherapy: A meta-analysis.Prediction of EGFR and KRAS mutation in non-small cell lung cancer using quantitative 18F FDG-PET/CT metrics.Pros: should a patient with stage IA non-small cell lung cancer undergo invasive mediastinal staging?Targeting the de novo biosynthesis of thymidylate for the development of a PET probe for pancreatic cancer imaging.Pretreatment 18F-Fluorodeoxyglucose Positron Emission Tomography Standardized Uptake Values and Tumor Size in Medically Inoperable Nonsmall Cell Lung Cancer Is Prognostic of Overall 2-Year Survival After Stereotactic Body Radiation Therapy.Clinical significance of Ki-67 and p53 expression in curatively resected non-small cell lung cancer.Use of pretreatment metabolic tumour volumes to predict the outcome of pharyngeal cancer treated by definitive radiotherapy
P2860
Q26771327-A7DB671A-8DEA-4517-AE09-8CBE4A6C5C57Q27021838-06A9FA8E-8FA2-4F2C-B510-6CD010937205Q33750851-9F57B52F-8894-4BB7-9AF3-4F3C3794D9E4Q34486542-DDBCE208-6B99-497E-8AD8-9F22D43930A6Q34846142-5F5E1CD9-EA9E-456F-B2A4-73B330BC70F8Q36621221-0C08CC83-C261-44AF-A5F2-3BB468989A31Q38583728-FCEE1A5B-261A-46A3-A04F-CBA27643866CQ38673771-0A7A001D-6446-4177-8668-3961169C01B2Q38925620-54BAF22D-15F9-4D56-A716-C8E1636B8467Q40053178-1F4A8B9F-35CE-487D-9D1E-DF2734255DE1Q42434579-DD26BEAB-F7D5-436F-A43C-B39A692A0FE9Q42555617-D6FDF042-94F7-4338-A457-0C10ED927005Q47173621-9D8B5AF5-5F4A-479D-9333-EF6B42C19F06Q51146037-A5FE59C4-AAEB-41C4-97A1-97690412A9F5Q58814272-4D8D6897-BBB2-4340-A66E-AFCE705E1EBE
P2860
Positron emission tomography 18F-fluorodeoxyglucose uptake and prognosis in patients with surgically treated, stage I non-small cell lung cancer: a systematic review.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Positron emission tomography 1 ...... g cancer: a systematic review.
@en
Positron emission tomography 1 ...... g cancer: a systematic review.
@nl
type
label
Positron emission tomography 1 ...... g cancer: a systematic review.
@en
Positron emission tomography 1 ...... g cancer: a systematic review.
@nl
prefLabel
Positron emission tomography 1 ...... g cancer: a systematic review.
@en
Positron emission tomography 1 ...... g cancer: a systematic review.
@nl
P2093
P1476
Positron emission tomography 1 ...... g cancer: a systematic review.
@en
P2093
Michael K Gould
Viswam S Nair
Yelena Krupitskaya
P304
P356
10.1097/JTO.0B013E3181BCCBC6
P577
2009-12-01T00:00:00Z